We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Paul Thompson

Paul D. Thompson MD

Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine, University of Connecticut, Storrs, Connecticut

Paul D. Thompson, MD, graduated from Tufts College and from Tufts Medical School. He served as a medical intern and resident at Tufts New England Medical Center and completed his training in cardiology at Stanford Medical Center.

Dr. Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine at the University of Connecticut. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992. He has authored over 450 scientific articles on topics which include: the treatment of cardiovascular risk factors, the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function, and genetic factors affecting the exercise response. His past and present NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of Coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia. Dr. Thompson is the Editor of the book Exercise and Sports Cardiology. He is a Past President of the American College of Sports Medicine.

Disclosures

Paul D. Thompson, MD, has been a member of the Speakers’ Bureau for Regeneron, Sanofi,  Boehringer-Ingelheim, Amgen, and Amarin; has served as a consultant for Amgen, Regeneron, Esperion, and Sanofi; has received research support from Sanofi, Regeneron, Esperion, Amarin, and Pfizer; owns stock in Abbvie, Abbott Labs, CVS, General Electric, Johnson & Johnson, Medtronic, Myocardia, and Sarepta; and has provided legal consultation on exercise-related cardiac events and statin myopathy.